LeonaBio (LONA) Cash from Operations (2019 - 2026)
LeonaBio (LONA) reported Cash from Operations of 20903000.0 for Q1 2026, down 42.54% year-over-year from 36376230.57 in Q1 2025, and down 7.76% on a QoQ basis from 19397000.0 in Q4 2025.
LeonaBio (LONA) has 8 years of Cash from Operations data on file, last reported at 20903000.0 in Q1 2026.
- Quarterly Cash from Operations fell 42.54% year-over-year to 20903000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51967000.0 (up 39.6% YoY) and the FY2025 annual result came in at 45729000.0, up 52.94% from the prior year.
- Cash from Operations fell to 20903000.0 in Q1 2026 per LONA's latest filing, from 19397000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4668000.0 in Q3 2025 and bottomed at 26293000.0 in Q4 2023.
- The 5-year median for Cash from Operations is 21640000.0 (2022), against an average of 19824941.18.
- The widest annual swing landed in 2022, when Cash from Operations sank 154.07%; it then jumped 79.72% in 2025.
- Tracing LONA's Cash from Operations over 5 years: stood at 15667000.0 in 2022, then plunged by 67.82% to 26293000.0 in 2023, then climbed by 1.06% to 26013000.0 in 2024, then grew by 25.43% to 19397000.0 in 2025, then fell by 7.76% to 20903000.0 in 2026.
- Per Business Quant, the three latest LONA Cash from Operations figures stand at 20903000.0 (Q1 2026), 19397000.0 (Q4 2025), and 4668000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -20.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.90 Mn |
| Mar 31, 2026 | -20.90 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Jun 30, 2024 | -22.33 Mn |
| Jun 30, 2024 | -22.33 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Mar 31, 2024 | -25.80 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Sep 30, 2023 | -23.98 Mn |
| Sep 30, 2023 | -23.98 Mn |
| Jun 30, 2023 | -24.28 Mn |
| Jun 30, 2023 | -24.28 Mn |
| Mar 31, 2023 | -26.19 Mn |
| Mar 31, 2023 | -26.19 Mn |
| Dec 31, 2022 | -15.67 Mn |
| Dec 31, 2022 | -15.67 Mn |
| Sep 30, 2022 | -21.64 Mn |
| Sep 30, 2022 | -21.64 Mn |
| Jun 30, 2022 | -18.59 Mn |
| Jun 30, 2022 | -18.59 Mn |
| Mar 31, 2022 | -16.57 Mn |
| Mar 31, 2022 | -16.57 Mn |
| Dec 31, 2021 | -18.18 Mn |
| Dec 31, 2021 | -18.18 Mn |
| Sep 30, 2021 | -10.30 Mn |
| Sep 30, 2021 | -10.30 Mn |
| Jun 30, 2021 | -7.32 Mn |
| Jun 30, 2021 | -7.32 Mn |
| Mar 31, 2021 | -7.31 Mn |
| Mar 31, 2021 | -7.31 Mn |
| Dec 31, 2020 | -10.67 Mn |
| Dec 31, 2020 | -10.67 Mn |
| Sep 30, 2020 | -9.41 Mn |
| Sep 30, 2020 | -9.41 Mn |
| Jun 30, 2020 | -2.86 Mn |
| Jun 30, 2020 | -2.86 Mn |
| Mar 31, 2020 | -1.18 Mn |
| Mar 31, 2020 | -1.18 Mn |
| Dec 31, 2019 | -1.03 Mn |
| Dec 31, 2019 | -1.03 Mn |